Editas Medicine vs Mammoth Biosciences
Editas Medicine vs Mammoth Biosciences, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and Mammoth Biosciences on 63/100.
Where each one leads
Editas Medicine
- agent readiness: 39/100 against 35/100
- domain rating: 61/100 against 53/100
Mammoth Biosciences
- our overall score: 63/100 against 42/100
- funding raised: $460M against $210M
At a glance
| Measure | Editas Medicine | Mammoth Biosciences |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. |
| Category | Biotech, MedTech, Genomics, Drug Discovery | Biotechnology, Drug Discovery, Genomics, CRISPR Technology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2017 |
| Headquarters | Cambridge, United States | Brisbane, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Editas Medicine | Mammoth Biosciences |
|---|---|---|
| Employees | 185 | 165 |
| Headcount growthLast 12 months | Not published | +5.8% |
| Total funding | $210M | $460M |
| Latest round | Series B | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 52,616 | 57,986 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Editas Medicine | Mammoth Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 63/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 27/100 | 35/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Editas Medicine | Mammoth Biosciences |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
Editas Medicine vs Mammoth Biosciences: common questions
Which is better, Editas Medicine or Mammoth Biosciences?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Editas Medicine and Mammoth Biosciences compare on the numbers?
Editas Medicine leads on agent readiness (39/100 against 35/100), domain rating (61/100 against 53/100). Mammoth Biosciences leads on our overall score (63/100 against 42/100), funding raised ($460M against $210M).
Read the full Editas Medicine review and pricing or the Mammoth Biosciences review and pricing. You can also browse other Editas Medicine alternatives we track.